Physician profile
Jennifer J Colavito
NPI 1699840074
$2,792.65
in general payments reported to CMS, 2019-2025
15 companies · $647 in 2025
The $647 reported for 2025 was more than what 88% of Vision Therapy providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $177 · 2021: $80.40 · 2022: $366 · 2023: $676 · 2024: $334 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,657.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $605.40 | 2019-2023 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $445.20 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Johnson & Johnson Vision Care, INC. | $429.06 | 2022-2025 | Acuvue |
| Oyster Point Pharma, INC. | $297.78 | 2022-2025 | Tyrvaya, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $295.38 | 2021-2025 | Cequa |
| Alcon Vision LLC | $293.64 | 2019-2025 | Total30, Precision7, Precision 1 |
| Tarsus Pharmaceuticals, INC. | $181.04 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $97.44 | 2020-2023 | |
| Harrow Eye, LLC | $26.52 | 2024 | Vevye |
| Thea Pharma INC. | $25.00 | 2023 | |
| Biotissue Holdings INC. | $20.37 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.09 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Kala Pharmaceuticals, INC. | $19.31 | 2021 | |
| Shire North American Group INC | $17.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Colavito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.